Cargando…
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness
Mutation of the 3β-hydroxysterol Δ(7)-reductase gene (Dhcr7 (−/−)) results in Smith-Lemli-Opitz syndrome (SLOS). Patients, and genetically altered mice, are unable to produce cholesterol and accumulate 7-dehydrocholesterol (DHC) in serum and tissue. This causes multiple growth and developmental abno...
Autores principales: | Kovarova, Martina, Wassif, Christopher A., Odom, Sandra, Liao, Katherine, Porter, Forbes D., Rivera, Juan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121200/ https://www.ncbi.nlm.nih.gov/pubmed/16618793 http://dx.doi.org/10.1084/jem.20051701 |
Ejemplares similares
-
Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update
por: Thurm, Audrey, et al.
Publicado: (2016) -
Smith-Lemli-Opitz-syndrome
por: Gedam, Rachana, et al.
Publicado: (2012) -
A Placebo-Controlled Trial of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
por: Wassif, Christopher A., et al.
Publicado: (2016) -
Reduced cholesterol levels impair Smoothened activation in Smith–Lemli–Opitz syndrome
por: Blassberg, Robert, et al.
Publicado: (2016) -
Smith-Lemli-Opitz Syndrome: Bosnian and Herzegovinian Experience
por: Begic, N, et al.
Publicado: (2021)